Ignite Creation Date:
2024-05-06 @ 6:54 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05829356
Status:
COMPLETED
Last Update Posted:
2024-05-09
First Post:
2023-04-06
Brief Title:
Substudy 01 - Safety and Immunogenicity of One Monovalent Modified mRNA Vaccine Encoding Influenza Hemagglutinin With LNP in Adult Participants Aged 18 to 49 Years and 60 Years and Above
Sponsor:
Sanofi Pasteur a Sanofi Company
Organization:
Sanofi
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-04-12
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-03-14
Completion Date Type:
ACTUAL
First Submit Date:
2023-04-06
First Submit QC Date:
April 24 2023
Study First Post Date:
2023-04-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-08
Last Update Post Date:
2024-05-09
Last Update Post Date Type:
ACTUAL